- Model for End-Stage Liver Disease,
- liver cirrhosis,
How to Cite
Copyright (c) 2023 Anche Volkanovska, Violeta Dejanova, Vladimir Andreevski, Meri Trajkovska, Danica Labudovikj
This work is licensed under a Creative Commons Attribution 4.0 International License.
Aim of the study: To investigate plasma D-dimer levels in correlation with Child-Pugh-Turcotte (CTP) and Model for End-Stage Liver Disease (MELD) scores in patients with liver cirrhosis (LC) of different severity, as well as the correlation with LC-associated clinical, biochemical parameters and complications. Material and methods: Fifty patients with LC were divided in three groups according to LC severity using the CTP Score (CTP-A, CTP-B, CTP-C). The levels of D-dimer were measured in sodium-citrate plasma on Siemens, BCS XP Blood Coagulometer. Kruskal-Wallis test was used to compare D-dimer levels between the groups. Mann-Whitney U test was used to evaluate the difference of D-dimer levels in groups with different MELD score, and to evaluate the difference in D-dimer levels in patients with presence or absence of ascites and the difference of D-dimer levels in patients with or without spontaneous bacterial peritonitis (SBP). Pearson’s coefficient of correlation was used to evaluate the correlation between D-dimer levels with MELD score and the correlation between D-dimer levels and the concentration of LC-associated biochemical, clinical parameters and complications. Results: D-dimer levels increased with severity of the disease as assessed with CTP and MELD scores, with a statistically significant difference between the groups (p=.0000 and p=.0001, respectively). Group CTP-C demonstrated the highest D-dimer levels, followed by groups B and A. Patients with SBP had significantly higher levels of D-dimers than patients without SBP (p=.0006). A significant positive correlation between D-dimers and CTP and MELD score was detected (r= 0.74 and r=0.44, respectively; p<.001). A correlation between D-dimer levels and several biochemical parameters characterizing progressive liver dysfunction was observed. From all investigated biochemical parameters, the highest significant correlation was detected between D-dimer levels and the concentration of serum albumin (r= -0.65, p<.001). Conclusions: Plasma D-dimer levels are tightly correlated with the degree of liver dysfunction and LC-associated complications. Therefore, D-dimer levels could be utilized as a prognostic stratification marker and adjunctive diagnostic marker in LC-associated complications.
- Rodger MA, Le Gal G, Wells P, et al. Clinical decision rules and D-Dimer in venous thromboembolism: current controversies and future research priorities. Thromb Res 2014;134(4):763-768.https://doi.org/10.1016/j.thromres.2014.07.031
- Geersing GJ, Janssen KJ, Oudega R, et al. Excluding venous thromboembolism using point of care D-dimer tests in outpatients: a diagnostic meta-analysis. BMJ. 2009;339:b2990. https://doi.org/10.1136/bmj.b2990
- Palareti G, Cosmi B, Legnani C, et al. D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study. Blood 2014;124(2):196-203.https://doi.org/10.1182/blood-2014-01-548065
- Tripodi A. Hemostasis in Acute and Chronic Liver Disease. Semin Liver Dis 2017;37(1):28-32.https://doi.org/10.1055/s-0036-1597770
- Northup PG, Caldwell SH. Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol. 2013;11(9):1064-1074.https://doi.org/10.1016/j.cgh.2013.02.026
- Cioni G, Cristani A, Mussini C, et al. Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients. Ital J Gastroenterol. 1990;22(2):70-74.
- Saray A, Mesihovic R, Gornjakovic S, et al. Association between high D-dimer plasma levels and ascites in patients with liver cirrhosis. Med Arch 2012; 66(6):372-4.https://doi.org/10.5455/medarh.2012.66.372-374
- El Gohary AM, Elyamany AS, Mikhael NL, Mahmoud MG, Tawfik MMR. Serum and ascitic D-dimer in cirrhotic patients with spontaneous bacterial peritonitis. Clin Exp Hepatol. 2021;7(2):134-140.https://doi.org/10.5114/ceh.2021.105915
- Dai J, Qi X, Li H, Guo X. Role of D-dimer in the development of portal vein thrombosis in liver cirrhosis: A Meta-analysis. Saudi J Gastroenterol. 2015;21(3):165-174. https://doi.org/10.4103/1319-3767.157567
- Li Y, Qi X, Li H, et al. D-dimer level for predicting the in-hospital mortality in liver cirrhosis: A retrospective study. Exp Ther Med. 2017;13(1):285-289.https://doi.org/10.3892/etm.2016.3930
- Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg 1964;1:1-85.https://pubmed.ncbi.nlm.nih.gov/4950264/
- Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124(1):91-96.https://doi.org/10.1053/gast.2003.50016
- El-Sayed R, El-Karaksy H, El-Raziky M, et al. Assessment of coagulation and fibrinolysis in children with chronic liver disease. Blood Coagul Fibrinolysis 2013; 24(2):113-117.https://doi.org/10.1097/MBC.0b013e3283569297
- Cong YL, Wei YX, Zhang LW, Yin ZJ, Bai J. The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores. Zhonghua Gan Zang Bing Za Zhi. 2005;13(1):31-34. Chinese.https://pubmed.ncbi.nlm.nih.gov/15670488/
- Violi F, Ferro D, Basili S, et al. Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastroenterology 1995;109(2):531-539.https://doi.org/10.1016/0016-5085(95)90342-9
- Primignani M, Dell'Era A, Bucciarelli P, et al. High-D-dimer plasma levels predict poor outcome in esophageal variceal bleeding. Dig Liver Dis 2008; 40(11):874-881.https://doi.org/10.1016/j.dld.2008.01.010
- Kalra A, Wedd JP, Biggins SW. Changing prioritization for transplantation: MELD-Na, hepatocellular carcinoma exceptions, and more. Curr Opin Organ Transplant 2016; 21(2):120-126.https://doi.org/10.1097/MOT.0000000000000281
- Agarwal S, Joyner KA Jr, Swaim MW. Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease. Am J Gastroenterol. 2000;95(11):3218-3224. https://doi.org/10.1111/j.1572-0241.2000.03299.x
- Lisman T, Leebeek FW, Mosnier LO, et al. Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology. 2001; 121(1):131-139.https://doi.org/10.1053/gast.2001.25481
- Colucci M, Binetti BM, Branca MG, et al. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis. Hepatology 2003; 38(1):230-237.https://doi.org/10.1053/jhep.2003.50277
- Romanelli R, Cellai A, Lami D, et al. D-dimer and fibrinolytic activity in patients with decompensated liver cirrhosis. Digest Liver Dis 2015; 47: e33. https://doi.org/10.5114/ceh.2021.105915
- Wesam AI, Abdelhakam S, Helmy A, et al. Evaluation of plasma D-dimer level in patients with chronic liver disease. Researcher 2011; 3: 13-18.
- Weiyi X, Baode C, Qing X. The application of plasma D-dimer in the diagnosis of spontaneous peritonitis in cirrhotic patients with ascites. Int J Lab Med 2014; 21: 2883-2884.
- European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397-417.https://doi.org/10.1016/j.jhep.2010.05.004
- Komolafe O, Roberts D, Freeman SC, et al. Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev 2020;1(1):CD013125.https://doi.org/10.1002/14651858.CD013125.pub2